Foundation News

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program. 

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that Dr. Brent Polk (University of California San Diego) has been appointed Chair of its national Board of Trustees, and that three new trustees have been elected to the Board.

NEW YORK, NY – The Crohn's & Colitis Foundation, the leading non-profit dedicated to finding cures for inflammatory bowel disease (IBD) and improving patient quality of life, launched a new public service announcement (PSA) campaign to increase familiarity with the symptoms of Crohn’s disease

The Crohn's and Colitis Foundation enters partnership with LifeArc to develop first clinical tests to predict disease course and response to treatment in pediatric Crohn's patients.

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer Inc., has announced the results of a request for proposal (RFP) to reduce health disparities that exist around vaccine usage and health maintenance in patients with inflammatory bowel disease (IBD). 

The American College of Gastroenterology (ACG) and The Crohn’s & Colitis Foundation (the Foundation) are proud to announce their joint publication of “Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States” in both

After serving 4 years as co-Editor of the journal Fabio Cominelli, MD, PhD, has been named Editor-in-Chief and Sonia Friedman, MD, FACG, who is joining the editorial leadership, has been named Deputy Editor.

Washington, D.C. - Today 29 patient and consumer groups representing millions of people nationwide with pre-existing health conditions issued the following statement in response to administration’s final rule.

NEW YORK, NY – The Crohn’s & Colitis Foundation (Foundation), in partnership with Pfizer, Inc., announce a Request for Propo

NEW YORK, NY – Today, 48 national health organizations sent a letter to members of Congress urging them to fund critical education about COVID-19 and cancelled research activities as a result of the pandemic. 

The Crohn’s & Colitis Foundation (the Foundation) is pleased to announce five new members of its National Board of Trustees, which oversees the management of the organization’s policies, practices, principles, affairs, funds, and property.